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Abstract 
Solventogenic clostridia offer a sustainable alternative to petroleum-based production of butanol—an 
important chemical feedstock and potential fuel additive or replacement.  C. beijerinckii is an attractive 
microorganism for strain design to improve butanol production because it (i) naturally produces the 
highest recorded butanol concentrations as a byproduct of fermentation; and (ii) can co-ferment pentose 
and hexose sugars (the primary products from lignocellulosic hydrolysis).  Interrogating the metabolism 
of this microorganism from a systems viewpoint using constraint-based modeling allows for simulation of 
the global effect of various genetic modifications.  We present the first genome-scale metabolic model 
(iCM925) for C. beijerinckii, containing 925 genes, 938 reactions, and 881 metabolites. To build the 
model we employed a semi-automated procedure that integrated genome annotation information from 
KEGG, BioCyc, and The SEED, and utilized computational algorithms and extensive manual curation to 
improve model completeness. Interestingly, we found only a 34% overlap in annotation information 
between the three databases—highlighting the importance of evaluating the predictive accuracy of the 
resulting genome-scale model. To validate the iCM925 model we conducted fermentation experiments 
using the NCIMB 8052 strain, and evaluated the ability of the model to simulate substrate uptake and 
product production rates.  Experimentally observed fermentation profiles were found to lie within the 
solution space of the model; however, under an optimal growth objective, the model was unable to 
reproduce the observed profiles without additional constraints.  Notably, a significantly enriched fraction 
of actively utilized reactions in simulations—constrained to reflect experimental rates—originated from 
the set of reactions that overlapped between all three databases (P = 3.52x10
-9, Fisher’s exact test). 
Inhibition of the hydrogenase reaction was found to have the largest effect on butanol formation—a 
relationship that has been experimentally observed.  Our findings show that the iCM925 is a predictive 
model that can accurately reproduce physiological behavior and provide insight into the underlying 
mechanisms of microbial butanol production. As such, the model will be instrumental in efforts to better 
understand, and metabolically engineer, this microorganism for sustainable butanol production.  
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Chapter 1: Introduction  
The diminishing supply of non-renewable feedstocks—and concern over environmental ramifications of 
their use in fuel and chemical production—highlights the need for technological advances to improve the 
economic viability of sustainable production methods.  In particular, given its broad scope of applications 
as a chemical feedstock  and compelling properties as an alternative transportation fuel [1], sustainable 
production of butanol is of particular industrial interest.  Butanol production via microbial fermentation 
from lignocellulosic material (historically achieved using solventogenic clostridia, prior to petroleum 
refining [2]) represents a sustainable method for production of this important solvent.  
 
More recently, the most common fermentation microorganisms—Escherichia coli and Saccharomyces 
cerevisiae—have been engineered to produce butanol and its branched chain derivatives (e.g., isobutanol) 
[3-5].  However, relative to E. coli and S. cerevisiae, the solventogenic clostridia offer two clear 
advantages as butanol-producing microorganisms: (i) the evolved ability to produce and tolerate butanol 
at concentrations up to 21 g/L—important because butanol is highly toxic to microorganisms at even low 
concentrations [6-9], and (ii) the ability to co-ferment pentose and hexose sugars, the primary sugars 
found in lignocellulosic hydrolysates [10, 11].  These characteristics should reduce the number of genetic 
modifications needed to make bio-butanol production economically competitive.  
 
Among the solventogenic clostridia, Clostridium acetobutylicum ATCC 824 and C. beijerinckii produce 
the highest n-butanol concentrations; the mutant strain C. beijerinckii BA101 achieves the highest 
reported concentration (17-21 g/L) across all microorganisms [7-9].  The parent strain of BA101, C. 
beijerinckii strain NCIMB 8052, holds several advantages for industrial butanol production: (i) it has 
proven amenable to experimental modifications that increase butanol tolerance and production [9]; (ii) the 
solventogenic genes reside on the chromosome rather than on a separate megaplasmid  (as is the case for 
C. acetobutylicum), potentially increasing its resistance to degeneration [12]; (iii) it can successfully 
produce butanol in continuous culture conditions [13]; and (iv) it has a broad substrate utilization 
spectrum [10, 11, 14].  Taken together, these traits give C. beijerinckii particular appeal as a clostridial 
catalyst for industrial butanol production. 
 
Like other solventogenic clostridia, C. beijerinckii produces solvents (butanol and acetone) as products of 
a biphasic metabolism.  Butyrate and acetate are produced first in acidogenesis; in solventogenesis, acids 
are re-assimilated and production of butanol and acetone begins.  Central to improving butanol production 
is deciphering what causes this metabolic switch. Numerous phenomena—decreased pH, acid 
accumulation, intracellular ATP concentration, nutrient limitation, interplay between carbon and electron 
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flow pathways, and sporulation—have been hypothesized to contribute [15, 16].  Most of these 
phenomena are directly tied to cellular metabolism, or more specifically, to changes among the enzymes 
and metabolites that comprise the intracellular metabolic network.  Our aim is to develop an 
understanding of C. beijerinckii metabolism—through systems analysis of the metabolic network—that 
will enable us to optimally direct available carbon towards the production of butanol.   
 
In silico reconstruction of metabolic networks—and subsequent analysis of genome-scale metabolic 
models—enables a global interrogation of metabolism not possible through standard experiments.  The 
genome-scale model allows one to analyze the cell from a systems viewpoint to predict whole-cell effects 
of genetic changes, and to simulate known and hypothesized phenotypes.  Methods for reconstructing and 
analyzing metabolic networks have been well established for microorganisms, and genome-scale models 
have been built for all branches of life [17].  Furthermore, numerous successes have been demonstrated 
for using these models to guide rational engineering in model microorganisms such as E. coli and S. 
cerevisiae [18-20].  Importantly, models of this type can now be constructed for any organism with a 
sequenced genome, and thus hold particular utility for lesser characterized organisms such as C. 
beijerinckii.   
 
We have built the first genome-scale metabolic model (named iCM925) for C. beijerinckii NCIMB 8052. 
There have been four genome-scale models built for clostridia—two for C. acetobutylicum [21-23] and 
one each for the cellulolytic strains C. thermocellum [24] and C. cellulolyticum [25].  C. beijerinckii is 
unique from these in that it is the most productive wild-type butanol-producing clostridia known to date 
[6-9].  Containing 925 genes, 938 reactions, 881 metabolites, and 67 membrane transport reactions, the 
iCM925 model is the largest genome-scale model for a clostridial species.  The iCM925 model accurately 
simulates substrate uptake and product formation rates for batch culture, and correctly captures the 
relationships between the formation of products such as butanol and hydrogen.  As such, the C. 
beijerinckii model will be instrumental in our future efforts to reengineer C. beijerinckii NCIMB 8052 to 
produce higher titers of butanol. 
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Chapter 2: Materials and Methods 
Genome-scale models are built using enzyme-catalyzed reaction information encoded in the genome of an 
organism, as well as experimentally characterized reaction information.  This collection of all known 
reactions in the metabolism of the organism then serves as the foundation for the metabolic model.  The 
model is represented mathematically by the stoichiometric (S) matrix.  Each column in S represents a 
reaction in the network, where entries for each row indicate the stoichiometric relationship of 
corresponding metabolites (negative and positive coefficients denote reactants and products, respectively, 
and zero entries indicate a non-participating reaction).  Through constraint-based modeling [50, 51], a 
series of balances and bounds (discussed below) are applied to the reactions in S, and the model is used to 
simulate cell growth by optimizing for a user-defined objective function.  These simulations can then be 
used to examine the interplay between different reactions and pathways, and to predict resulting 
metabolic phenotypes from genetic modifications.  
 
2.1 Semi-automated compilation of the draft metabolic network 
The metabolic network describes the connectivity of metabolites and reactions in a cell and characterizes 
the link between genes, proteins and reactions (GPR relationship).  We built the base metabolic network 
using the KEGG gene annotation for C. beijerinckii.  This draft network contained annotation-based 
information available for C. beijerinckii from the KEGG database, including GPR relationships, pathway 
information, reaction stoichiometry, and reaction reversibility.  The time needed to generate the initial 
draft network was drastically reduced by automatically collecting and organizing the network information 
using the KEGG FTP server.  
 
The KEGG draft network was augmented using independent annotations from The SEED and from 
BioCyc.  Annotations in The SEED database are linked to KEGG biochemical data, making integration of 
the two networks straightforward.  BioCyc, however, employs a different nomenclature, so we 
constructed a mapping between reaction and metabolite IDs in BioCyc and KEGG for C. beijerinckii.  
Specifically, metabolites were mapped using (i) BioCyc files linking to KEGG (incomplete); (ii) 
compound names and unique iNICHi identifiers; (iii) the E. coli specific mapping for iAF1260 [52]; and 
(v) manual curation.  Between-database reaction mapping was then determined as follows:  
i. using the between-database metabolite mapping, we identified the set of all compounds 
shared by BioCyc and KEGG;  
ii. we built temporary S matrices (one for the BioCyc C. beijerinckii  reaction set, one for the 
our KEGG/SEED draft network set, and one for the BiGG database—including only those 
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reactions involving metabolites in the shared set (metabolites were ordered identically in each 
matrix);  
iii. we identified matching columns (reactions), assuming that identical stoichometric 
relationships between a set of metabolites represented a matching reaction between BioCyc 
and KEGG.  
iv. we manually inspected and curated reactions not mapped in an automated fashion. 
  
The resulting network, based on KEGG nomenclature, consisted of the list of reaction formulas, the 
corresponding enzymes (including enzyme commission number) and genes, reaction identifiers, pathway 
information, and a note on the source database.  To enable comparison with other published genome-scale 
models (over 50 to date [19]), the metabolite and reaction identifiers were reformatted in accordance with 
models available in the BiGG database [30].  This was done similarly to the BioCyc-KEGG mapping.  
Metabolite mapping was achieved using flat files from BiGG, and reactions were mapped using 
temporary S matrices for BiGG and the C. beijerinckii network.  Manual matching was performed for 
reactions and metabolites for which no automated connection was found.  Names were generated for any 
remaining reactions and metabolites for which no mapping existed.  
 
2.2 Building the genome-scale metabolic model 
In order to simulate cellular behavior based on a defined set of inputs and outputs, the network derived 
from KEGG, BioCyc, and The SEED was converted into a genome-scale metabolic model.  As described 
above, the stoichiometric matrix (S) contains the primary model information.  The fundamental equation 
used to model the system is based on the net mass balance of reactions in the network, defined by: 
dt
dx
vS  
where dx/dt is change in metabolite concentration over time and the flux vector v represents the rate of 
biomolecular conversion for each reaction (units of mmol/gDW/hr).  Constraint-based modeling typically 
assumes steady state operation (mass into the cell equals mass out), leading to the following mass balance 
constraint: 
0vS  
When building the model, application of physic-chemical constraints—namely mass and energy 
balance—were carefully enforced.  To mass- and charge-balance model reactions, charge information for 
each molecule was determined using (in order): (i) the BiGG database; (ii) computational pKA based 
predictions at pH 7.2; and (iii) BioCyc (see Appendix A for complete list).  The model was then mass 
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balanced in a semi-automated fashion using charged molecular formulas.  Reactions with a hydrogen 
imbalance were balanced by altering the stoichiometric hydrogen relationship until both mass and charge 
balance were satisfied.  Reactions that could not be balanced in this manner were inspected manually.  
Any reactions that ultimately could not be balanced were excluded from simulations.  
 
We applied environmental constraints as bounds on individual fluxes (e.g., flux capacities, 
thermodynamics), defining the smaller solution space that represents the model’s allowable phenotypes.  
Irreversible reactions were constrained to positive or negative flux, depending on direction.  Membrane 
transport and exchange reactions were used to transfer metabolites into and out of the cytosol and system 
boundaries, respectively.  For metabolites whose uptake or output rates were experimentally determined, 
we specified individual bounds (e.g., glucose, acetate) on the corresponding exchange reactions, and these 
were varied depending on the simulation.  Reversibility was determined by careful comparison of reaction 
direction in all databases, and the most common directionality was typically chosen.  We used extreme 
pathway analysis [53, 54] to identify thermodynamically infeasible cycles, and eliminated these cycles by 
changing directionality of or deleting one of the participating reactions.  
 
As the constraint-based system is highly underdetermined, many solutions (i.e., flux distributions) exist 
that satisfy Sv = 0.  We therefore used Flux Balance Analysis (FBA) to determine the distribution of 
reaction fluxes that optimize a user-defined biological objective function (in our simulations, the 
commonly used biomass production objective) [44, 55].  To facilitate simulations, the model was 
formatted to be compatible with the COBRA Toolbox [47]; all model simulations were subsequently 
performed using COBRAToolbox-1.3.1 in MATLAB, with GLPK as the linear programming solver.  For 
all optimizations, the minNorm flag was on (related to the cost of enzyme production in the cell), and 
simulations were run with a negative lower bound representing a reversible reaction.  When performing 
Flux Variability Analysis, we selected reactions that could increase or decrease by 25% of their maximal 
flux value for further analysis.  
 
To simulate biomass production, a single equation representing all macromolecules comprising one C. 
beijerinckii cell was created using known experimental compositions and compositions inferred from the 
genome.  Following the C. acetobutylicum biomass formulation used by Lee et al. [21], biomass was 
assumed to consist of: DNA, RNA, lipids, protein, peptidogylcan, and techoic acid and trace metabolites. 
DNA, RNA and protein content were calculated directly from the genome sequence, and peptiodoglycan, 
technoic acid and trace metabolites were kept similar to C. acetobutlylicum. To determine the appropriate 
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lipid composition, we performed a detailed analysis of lipid and fatty acid content in the cell using data 
from [34].  See Appendix A for more details. 
 
2.3 Refinement of the genome-scale metabolic model 
As defined by Kumar et al., metabolites that participate in network gaps fall into two categories: non-
produced or non-consumed.  We first used GapFind/GapFill [32], which identifies network gaps and 
suggests reactions (from a user-specified database—in our case, the BiGG database) whose addition to 
the model would eliminate the gap.  Suggested reactions were manually inspected for relevancy and 
homology evidence using BLAST [31]; reactions with an E-value of 1x10
-8
 or less for their associated 
gene were added to the model.  This liberal cut off was used in an effort to achieve biomass growth—
added reactions were later curated by hand, and the total number of reactions added to the final model 
was reduced. 
 
Additional model refinement was carried out using reactions described in published C. beijerinckii 
material, as well as the two published C. acetobutylicum genome-scale models [21-23].  Reactions added 
from the C. acetobutylicum models were added in the same manner as the GapFill suggestions, with a 
required BLAST [31] E-value of no more than 1x10
-8
.  In only a few cases, reactions were added without 
any genomic evidence, given sufficient literature support for the reaction.  Model refinement continued 
until the model was capable of simulating accurate growth and product formation.  
 
2.4 Experimental data collection & analysis 
The four fermentation studies were conducted at different temperatures: 30°C, 33°C, 35°C, and 40°C; 
each study was run in triplicate.  Cultures of C. beijerinckii 8052 were stored in spore form at 4°C in 
sterile H2O [7].  Spores were heat shocked for 10 minutes at 80°C, immediately transferred into an ice 
bath for 5 minutes, and inoculated into a 6% glucose filter-sterilized P2YE medium [9, 56].  The 
inoculum was incubated in an anaerobic chamber under N2:CO2:H2 (volume ratio of 85:10:5) atmosphere 
for 14 hours at 35±1°C. Cell cultures were then transferred into 1 L Sixfors Bioreactors (Appropriate 
Technical Resources, Inc) containing 400 mL 6% glucose filter-sterilized P2 medium under anaerobic 
conditions for a 100 hour total fermentation period.  Over this time period, samples were taken every 3 
hours for the first 24 hours, 6 hours for the next 12 hours, 12 hours for the next 24 hours, and then every 
24 hours for the remainder of the time.  For each sample, optical density was measured using a UV-
Visible Spectrophotometer (Thermo Scientific BioMate 3) and cell density was calculated using the 
relationship A600 = 1 equivalent to 0.28 mg/mL.  Gas chromatography (Agilent Technologies 7890A GC 
System) was used to quantify acetic acid, acetone, butyric acid, ethanol, and butanol concentrations, and 
  
7 
 
glucose concentration was determined using high pressure liquid chromatography (Agilent Technologies 
1200 Series).  The pH was recorded throughout the fermentation.  
 
For each fermentation run, substrate uptake or product formation rates were calculated using the 
following equation [57], and then averaged across each temperature condition:  
μ
Δ[biomass]
te]Δ[metaboli
rate 
. 
In this equation, [metabolite] is the metabolite concentration in mmol/L, [biomass] is the cell 
concentration in gDW/L and µ is the growth rate.  The yield Δ[metabolite]/ Δ[biomass] was determined 
by plotting metabolite concentration against biomass concentration.  Growth rate was found using an 
exponential growth fit to the biomass vs. time plots.  To test the ability of iCM925 to reproduce the 
experimental rates, an experimental ―range‖ was defined as within one standard deviation above or below 
the mean.  This range was used to constrain the upper and lower bounds of the relevant uptake and output 
reactions in the model, and the resulting in silico growth prediction was compared to the experimental 
growth rate. 
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Chapter 3: Results and Discussion 
The first step towards building a genome-scale metabolic model is reconstructing the genome-scale 
metabolic network—typically done using publically available annotation databases and published 
literature. A list of reactions that are either catalyzed by enzymes encoded in the genome or have been 
defined experimentally is collected and then expanded to define relationships between genes, enzymes, 
reactions, metabolites, and pathways in the network.  To establish the genome-scale metabolic model, the 
network reactions are subjected to a series of physico-chemical constraints—either calculated or based on 
physiological data—to simulate defined cultural conditions.  Given the limited literature and biochemical 
data available for C. beijerinckii, we reconstructed our metabolic network using a semi-automated 
approach to obtain annotation data from three major databases, and utilized computational algorithms to 
further refine the network.  To test the iCM925 model’s ability to simulate experimentally-observed 
behavior, we conducted a series of batch fermentations to compare measured substrate uptake and product 
formation rates with model predictions.  The model provides a solid basis with which to study the unique 
characteristics of C. beijerinckii metabolism and guide future metabolic engineering experiments for 
enhanced butanol production capability. 
 
3.1 The initial genome-scale metabolic network 
The available genome annotations for lesser-characterized organisms are largely generated by 
computational, informatics-based procedures (i.e., they often lack manual curation), and there is a paucity 
of experimentally-confirmed biochemical data.  To facilitate reconstruction, expand the scope of our C. 
beijerinckii network, and evaluate confidence for each gene-protein-reaction (GPR) relationship included, 
we merged annotation data from three independent databases: KEGG (Kyoto Encyclopedia for Genes and 
Genomes) [26], BioCyc [27], and The SEED [28, 29].  To reduce the time required to assemble 
annotation data into a well-connected genome-scale network, we employed a semi-automated 
computational approach to retrieve and integrate information from each database. 
 
The foundation for our network, comprising 525 reactions, was obtained from the KEGG database.  We 
expanded this network to include an additional 75 and 136 unique reactions from The SEED and BioCyc 
databases, respectively.  Careful reconciliation and integration of the obtained biochemical data was 
required because the three databases do not follow a uniform nomenclature for reactions, metabolites, and 
pathways.  We chose to adhere to the nomenclature used by the BiGG database (the largest available 
repository for genome-scale metabolic models) in order to enable easier comparison with other in silico 
models [30].  This mapping step was quickly accomplished by using a matrix formalism to overlay the 
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different databases (see Methods) based on stoichiometry.  The mapping between BioCyc and KEGG for 
reaction and metabolite names in C. beijerinckii is available in Appendix A.   
  
We analyzed the overlap between annotation information collected from KEGG, BioCyc, and The SEED 
to help assess the confidence for each reaction included in the network.  Reactions found in all three 
databases were considered to have the greatest reliability, followed by reactions in two of the databases, 
and finally by reactions found in only one database.  Surprisingly, out of the collective 776 suggested 
reactions, we found only 264 reactions present in all three annotations (Figure 1).  Given that many 
genome-scale models are built in this manner, the small overlap observed for C. beijerinckii suggests that 
researchers must exercise caution when constructing networks for new organisms based on 
bioinformatics-based annotations alone.  The reconstruction and phenotypic testing of genome-scale 
models then provides an important means to integrating, curating, and validating annotation information.  
Further analysis of the relationship between database contribution and model accuracy (used to evaluate 
annotation quality for C. beijerinckii) is discussed below. 
 
In addition to establishing confidence for each included reaction, we evaluated the predicted gene-
associations for reactions found in two or more of the annotation databases (see Appendix B for 
database-based GPR comparison).  In cases where annotations did not agree between databases, 
associations were selected for the model based on the strongest BLAST [31] evidence (i.e., genomic 
identity between the associated enzyme and similarly annotated database proteins).  Reassuringly, we 
found that most annotation disagreements were due to a missing gene–reaction relationship rather than a 
contrasting association; this suggests that overlapping reactions comprise a well annotated area of the 
network.  
 
3.2 The refined C. beijerinckii metabolic network 
The draft metabolic network derived from genome annotation data—even with combined information 
from multiple databases—contained gaps (i.e., missing reactions) that prevented simulation of cell growth 
and accurate physiological behavior (e.g., butanol production).  Network gaps create unconnected 
sections/regions in the network, thereby preventing production or consumption of a metabolite.  In turn, 
the ―dead-end‖ metabolite has often been observed experimentally as consumed or produced, or is needed 
to simulate cell growth.  Network gaps must therefore be filled using literature information and/or 
genomic evidence beyond what was included in the annotation databases.  
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Identifying network gaps and selecting candidate gap-filling reactions with strong supporting evidence 
can be time consuming, especially for lesser-characterized organisms like C. beijerinckii.  Consequently, 
we used the GapFind and GapFill [32] algorithms to computationally identify and resolve gaps, thus 
minimizing the amount of manual curation needed.  Candidate reactions suggested by GapFill were 
chosen from the BiGG database; this database contains genome-scale models that have undergone 
extensive refinement and validation, and thus is a resource of high-confidence reactions [30].  After 
reviewing candidate reactions for sufficient BLAST [31] evidence, we identified an additional 22 putative 
annotations (and 22 additional network reactions) for the C. beijerinckii genome (see Appendix A)—
seven of which were required for simulated cell growth.   
 
Even after using GapFind and GapFill, manual addition of reactions was needed to fill important gaps that 
remained in the network.  Notably, the draft network was missing a butanol dehydrogenase enzyme, a 
ferredoxin NAD
+
 reductase, and did not contain the necessary biochemical transformations for production 
of known phospholipids.  Reactions for both an NAD
+
 and NADP
+
 butanol dehydrogenase enzyme 
(BUTOHDx and BUTOHDy), known to exist in solvent producing clostridia [2, 33], were added based on 
BLAST [31] scores for the C. beijerinckii gene Cbei_2421.  We were unable to find a gene association for 
ferredoxin NAD
+
 reductase—even though the NADP+ reductase is matched to Cbei_0661 and 
Cbei_2182—but added the reaction (FDXNRx) based on literature evidence [2].  The phospholipid 
pathway was characterized using a similar approach to Lee et al. [21], drawing upon experimental data for 
fatty acid biosynthesis [34].  In total, 38 reactions were added as a result of our manual curation—11 of 
which were added based on BLAST [31] comparison with reactions from the Senger & Papoutsakis C. 
acetobutylicum model [22, 23] and 22 of which were added for the formation of phosopholipid and 
biomass components.  
 
One of the most significant gaps in the draft C. beijerinckii network prevented model-simulated 
production of oxoglutarate, a major component of central metabolism; this gap stemmed from missing 
genetic evidence for enzymatic reactions need to complete the TCA cycle.  We completed the TCA cycle 
in the model based on conclusions from two recent experimental studies, in which carbon labeling 
showed that C. acetobutylicum uses a bifurcated TCA cycle culminating in succinate secretion [35, 36].  
The initial reconstruction did not support a bifurcated TCA cycle: our network was missing a citrate 
synthase (CS), succinyl-CoA synthetase (SUCOAS), and a succinate transport (SUCCex) reaction.  In 
addition, the directionality of existing reactions did not support the experimentally observed flux.  To 
allow for simulation of the bifurcated cycle and enable oxoglutarate production, we added the three 
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missing reactions (without genetic evidence), and restricted reaction directionality to that observed in the 
study.  
 
3.3 The genome-scale model (iCM925) 
From our refined metabolic network, we constructed the genome-scale model by representing the 
reactions, gene associations, pathway information, and reaction directionality in matrix form (see 
Appendix A for model details).  This model for C. beijerinckii, hereafter named iCM925 in accordance 
with the model naming convention proposed by Reed et al. [37] contains 938 reactions, 881 metabolites, 
and 925 genes—representing 18% of total protein coding genes in the genome [38, 39].  Transport 
reactions across the cell membrane—collected from the BioCyc and KEGG databases, as well as from the 
published C. acetobutylicum models [21-23] and the genome-scale models for Bacillus subtilis [40, 41]—
make up 67 of the 938 reactions.  iCM925 contains the largest number of genes, reactions and metabolites 
compared to the four other clostridial models (Table 1); this could be a result of model construction 
methods, but likely reflects the fact that C. beijerinckii has a 50% larger genome than the other clostridia.  
 
The reactions in iCM925 span 95 pathways (organized into 13 major groups in Figure 2), as defined by 
KEGG pathway nomenclature.  Carbohydrate and amino acid metabolism represent the largest portions of 
the network.  For each pathway, we calculated the percentage of reactions that can be utilized in glucose 
minimal media simulations (Figure 2) in order to evaluate model connectivity.  Overall, 47% of reactions 
across all pathways are blocked, which is on par with other in silico genome-scale models [42].  Many of 
these blocked reactions were concentrated within pathways that are almost entirely blocked, such as 
metabolism of terpenoids and polyketides—suggesting that many of the blocked reactions are actually a 
result of blocked pathways.  Pathways involving carbohydrate metabolism (compared to a more 
connected pathway such as nucleotide metabolism) may have a higher number of blocked reactions under 
glucose media conditions because they contain numerous reactions intended for metabolism on alternative 
sugar substrates.  
 
We assessed the pathway contribution of each annotation database (see Appendix C) to determine (i) if 
any database displayed more complete coverage in one area of metabolism (e.g., carbohydrate 
metabolism) and (ii) if one database contributed more blocked reactions to the model.  For each of the 13 
pathway categories depicted in Figure 2, we found similar coverage between KEGG, BioCyc, and the 
SEED; this indicates that the small overlap found between databases is not simply a result of one database 
contributing more heavily to a particular area of metabolism.  Additionally, each database contributed a 
similar number of blocked reactions: 22% of the blocked reactions came from BioCyc, 21% from KEGG, 
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10% from The SEED, 18% from two or more databases, and 17% from all three databases (these 
percentages are not directly proportional to the total number of enzymes contributed by each database).  
Therefore, we did not find that one database outperformed another in terms of model connectivity.   
 
3.4 Validation of iCM925 
To evaluate the predictive accuracy of iCM925, we used Flux Balance Analysis (FBA, see Methods) to 
reproduce experimental fermentation behavior.  The FBA formalism represents all known reactions in the 
cell as a stoichiometric matrix, and uses linear programming to maximize a user defined objective 
function (e.g., growth) under a steady state assumption [43, 44].  Importantly, FBA can be used to 
simulate experimental parameters such as growth rates, uptake rates, and byproduct secretion rates—
enabling quantitative evaluation of model agreement with physiological behavior.  
 
Data used to determine uptake and secretion rates for batch cultures was obtained by monitoring 
substrate, product, and cell concentrations in NCIMB 8052 cultures.  In a targeted gene expression study, 
Shi and Blaschek found that solvent formation began during mid-exponential growth (7-8 hours). This 
was characterized by increased expression levels of solvent formation genes and accompanied by 
decreased expression of genes associated with acids formation [15].  Similar to Shi and Blaschek, we 
observed the switch from butyrate to butanol formation at 8-10 hours—we chose to focus our simulations 
on the subsequent period of exponential growth in which butanol is produced.  We conducted 
fermentation studies at four temperatures (30°C, 33°C, 35°C, 40°C) to obtain multiple sets of data with 
which to compare model simulations, but only report results for 35°C in the main text, as it is most 
representative of typical fermentation conditions.  Complete experimental data for all tested conditions is 
available in Appendix D. 
 
Experimental estimates for substrate uptake and product secretion rates (in units of mmol/gDW/hr) were 
determined for butanol, acetone, ethanol, acetate and butyrate using product concentration and growth 
rate (see Methods, Appendix E).  All model simulations were conducted with biomass production 
(defined by the biomass equation) as the assumed cellular objective.  The biomass equation represents all 
macromolecules found in one C. beijerinckii cell, and was defined using known experimental 
compositions and compositions inferred from the genome (see Appendix A for details).  When 
performing simulations, specified uptake and secretion rates were constrained to fall within one standard 
deviation of experimentally measured rates, while the remaining rates were determined by FBA.   
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The first simulation of iCM925, with only glucose and acetate uptake rates constrained, predicted 
production of only acetone and butyrate, along with an elevated growth rate (Figure 3.A, see Appendix 
E for comparisons at different temperatures).  This product profile is not surprising for the assumed 
optimal growth objective, given the experimentally supported understanding of cellular redox in C. 
beijerinckii.  Specifically, disposal of excess electrons is achieved in cell culture through the generation of 
butyrate, butanol, and hydrogen.  However, disposal via hydrogen and butyrate would allow for ATP 
production with minimal loss of carbon, thereby improving the biomass objective.  Thermodynamic 
limitations of the hydrogenase reaction prevent such disposal biologically [2, 45], but such constraints 
were not incorporated into iCM925 explicitly because clear experimental hydrogen formation rates were 
unavailable.  Acetone production in the model could also be traced to acetate re-uptake: the formation of 
acetone utilizes acetoacetate, a byproduct of acetate re-uptake by CoA-transferase.  
 
Model and experimental values for product fluxes, uptake fluxes and growth rates represent conditions for 
the 35°C fermentation.  Error bars indicate the observed experimental range and diamonds represent the 
various simulation results. (A) shows the simulation results for the case where only acetate and glucose 
uptake rates are constrained. (B) shows the case where these uptake rates, as well as butanol, acetone, and 
butyrate formation rates are constrained. In (B), the blue diamonds represent the case where non-growth 
associated ATP maintenance is zero and the yellow diamonds represent the case where the non-growth 
associated ATP maintenance is 8.5.  
  
To confirm that iCM925 is capable of simulating production of all expected metabolites at experimentally 
determined rates, additional constraints were added to the product secretion reactions for butanol, acetone, 
ethanol, and butyrate (Figure 3.B, see Appendix E for comparisons at different temperatures).  As 
product formation is known to be associated with the generation of ATP in the cell [2], the effect of ATP 
production requirements were analyzed by altering the constraints on the non-growth associated ATP 
maintenance (NGAM) reaction.   The first simulation assumed that no ATP is needed for non-growth 
associated maintenance, and resulted in a higher growth rate than expected; this is a biologically 
unrealistic assumption, but illustrates the dependency of growth rate on ATP maintenance.  The latter 
simulation—with an NGAM value that guided the in silico growth rate to the experimentally calculated 
range—demonstrated that the expected experimental phenotype can be reproduced by the model. Thus, 
we concluded that all observed secretion patterns exist within the solution space of the model, even 
though solvent secretion patterns in C. beijerinckii are not very well described by the iCM925 model 
when using the optimal growth objective.     
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3.5 Analysis of the active reactions in iCM925  
After verifying that iCM925 could reproduce experimental uptake and secretion rates, we investigated the 
underlying flux distributions used by the model to achieve these rates.  Under optimal growth conditions 
for a defined minimal medium, a previous study found that genome-scale models for Helicobacter pylori, 
Staphylococcus aureus, E. coli, and S.cerevisiae have about 300 active reactions [42]; iCM925 had 291 
active reactions.  Interestingly, 137 of these 291 reactions (Figure 4) were found in all three annotation 
databases, representing a statistically significant number of active reactions among the overlapping 
reactions (P = 3.52x10
-9, Fisher’s exact test).  Since active reactions are those used by the model to 
reproduce known physiological behavior, the over-representation of reactions found in all three databases 
thus supports our assumption that overlapping reactions have the highest reliability for inclusion.   
 
To further study active reactions, we diagramed reactions carrying the largest flux in glycolysis, TCA 
cycle, and the product formation pathways (Figure 5).  In glycolysis, we found that the model used the 
PTS rather than ABC transporter to uptake extracellular glucose.  The choice of PTS over ABC suggests 
that C. beijerinckii may use the former transporter primarily as the most efficient means of converting 
glucose to biomass, a finding that is corroborated by experimental observation of PTS transport (GLCpts) 
utilization by C. beijerinckii [14, 16, 46].  Flux through the TCA cycle follows the experimentally 
observed route of oxoglutarate production [35] via citrate synthase (CS).  However, the model did not 
utilize the oxaloacetate to succinate transformation or the conversion of succinyl-CoA to succinate, as 
was observed by Amador-Noguez et al.  For succinyl-CoA synthetase (SUCOAS, an ATP generating 
reaction), we found that increased ATP requirements resulted in activation.   
 
Contrary to experimental ethanol production which stems primarily from acetyl-CoA [2, 40], iCM925 
predicted that about 70% of ethanol was made from threonine (derived from aspartate) by the enzyme 
threonine acetaldehyde-lyase (THRA).  Butanol, butyrate, and acetone were produced using the 
experimentally characterized pathways, and acetate was consumed using CoA-transferase (COAT1) as 
expected [2, 40].  Intriguingly, the model predicted simultaneous production and consumption of butyrate 
using butyrate kinase (BUTK) and CoA-transferase (COAT2), respectively.  The re-uptake of acids by 
solventogenic clostridia has been experimentally established, with one of the leading suggestions for this 
behavior being a means of de-toxification of the acidic environment [2].  Given that the primary objective 
in our simulations is to maximize flux through the biomass equation within the imposed constraints, it is 
most likely that the motivation for re-uptake of butyrate by the iCM925 model is the generation of 
additional ATP—a major component of biomass.  Previous experimental studies investigating acid re-
uptake [41-43] do not support this suggested motivation, however—making additional investigation into 
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the motivations of the model an interesting area of focus going forward.  These experimental findings 
further suggest that selective pressures other than optimal growth may dominate phenotype under typical 
fermentation conditions.  
 
Flux Variability Analysis (FVA) was performed to evaluate the robustness of our diagrammed reactions 
(Figure 6, see Appendix F for a complete list).  FVA calculates the extent to which network reactions 
can change without affecting the simulated maximal growth rate—the model represents an 
underdetermined system, and even when optimizing for a specific objective, multiple solutions exist for 
each set of constraints [47].  ACK, PTA, BUTK, BCOPBT, COAT1, and COAT2 are connected to the 
uptake and production of acetate and butyrate. As suspected, it is possible for both metabolites (either 
together or independently) to be simultaneously produced and consumed.  The variation seen in 
BUTOHDx and HACD1x indicates that either the NAD
+
 or NADP
+
 versions of these reactions can be 
used with no effect on growth rate. Similarly, the variation observed in PFL, POR4, and PYK show 
equally optimal methods of pyruvate formation and consumption.  
 
3.6 Understanding butanol production: the role of molecular hydrogen 
Hydrogen formation is known to play an important role in balancing cellular redox for C. beijerinckii, and 
has been found to effect the production of butanol [2, 48, 49].  Our simulations confirm this relationship, 
and also indicate the impact of hydrogen formation (and by extension butanol formation).  When grown 
on glucose and acetate, maximizing the specific growth rate leads to the formation of acetone and 
butyrate only; this simulation had a predicted hydrogen production rate of about 18 mmol/gDW/hr 
(Figure 7).  Our analysis showed that in order to observe positive butanol production, hydrogen 
production must be limited to below about 10 mmol/gDW/hr; the corresponding growth rate becomes 
sub-optimal with this constraint.  Since the production of ethanol and butanol both consume the same 
number of NADH molecules (two in each pathway), the model predicted that at low hydrogen production 
rates, either ethanol or butanol could be used to balance redox with no change in growth rate.   
 
H2 output flux was varied to examine the effect of hydrogen production on predicted formation rates for 
butyrate, acetone, butanol, ethanol, and biomass.  Glucose and acetate uptake rates were fixed to 9.39 and 
3.41 mmol/gDW/hr, respectively, and non-growth associated maintenance was set to 8.5 mmol/gDW/hr.  
Note that while positive ethanol formation is not depicted in the plot, FVA found ethanol and butanol 
production to be interchangeable, with no detrimental result to growth rate—likely because the net 
consumption of NADH is identical in both scenarios.  Experimentally, ethanol formation happens at a 
slower rate than butanol formation.  
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In an experimental C. acetobutylicum study, a decrease in hydrogenase activity (induced by carbon 
monoxide poisoning) when grown on glucose resulted in decreased growth rate, decreased acetone, 
acetate, and butyrate production, and increased ethanol and butanol production [49].  We found that 
iCM925 qualitatively predicts similar behavior for simulated growth on glucose only (acetate was not 
used as an input in this simulation to match experimental media conditions), suggesting that a similar 
mechanism might be involved in C. beijerinckii metabolism (Figure 8).  As with the other simulation, we 
found that butanol and ethanol production are interchangeable for these optimal growth simulations—in 
vivo, regulation likely factors in to dictate how much of each product is made.  This observation supports 
the conclusion that without hydrogen production, excess electrons are disposed of via the production of 
acids and solvents.   
 
Additionally, our simulation shows that for high levels of hydrogen formation, acetate is the only 
byproduct and growth rate is at a maximum.  The production of hydrogen eliminates the need for 
additional NADH consumption by butyrate, allowing ATP generation to occur exclusively via acetate 
formation—the most efficient method for the cell.  Maximum growth rate is observed under these 
conditions because they represent the most energy efficient means of glucose utilization for the 
microorganism.  At very low hydrogen consumption rates, we observe production of butanol rather than 
butyrate, as the production of butanol results in the consumption of two additional NADH molecules 
compared to butyrate. The overall observed effect of hydrogen formation is not only experimentally 
consistent, but it highlights the importance of this reaction in regulating butanol formation, and will be an 
area of focus in future work.  
 
3.7 Comparison of iCM925 with C. acetobutylicum model 
Although the genome of C. beijerinckii is 50% larger than that of C. acetobutylicum, the two 
microorganisms present phenotypically similar fermentation profiles.  To investigate the effect of 
additional genes in C. beijerinckii, we compared iCM925 to one of the C. acetobutylicum models (the 
model published by Senger and Papoutsakis in 2009 [22, 23]), using KEGG reaction IDs as a basis for 
comparison.  Of the 940 iCM925 reactions, 375 were found to overlap with the Senger model (Figure 9); 
183 of these reactions are present in our list of 291 active reactions for the 35°C (ATPM=8.5) 
fermentation simulation.  Interestingly, the pathways and database sources of the 564 reactions unique to 
iCM925 were similarly distributed as those of the full model—suggesting that (i) C. beijerinckii does not 
simply contain more reactions in a particular pathway, and (ii) that our additional reactions are not an 
artifact of our multiple database approach.  Of the 375 overlapping reactions, 119 have more connected 
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genes per reaction in C. beijerinckii than in C. acetobutylicum—with an average of 1.3 times more genes 
per reaction in C. beijerinckii. This is not a statistically significant result, but suggests that several of the 
reactions (e.g., CoA-transferase and butyrate kinase) do have more associated genes than the 
corresponding C. acetobutylicum reactions. 
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Chapter 4: Conclusions 
Butanol, currently produced as a byproduct of petroleum refining, is appealing in industry as both an 
important chemical feedstock and an alternative transportation fuel.  We have built the first genome-scale 
model for C. beijerinckii to better understand the metabolic behavior of the microorganism, and to guide 
future metabolic engineering for increased butanol production.  Having a genome-scale model for C. 
beijerinckii is advantageous because it helps provide a global picture of metabolism—this enables 
interrogation of the interplay between the various fermentation products of the microorganism from a 
systems viewpoint.  Given the lack of detailed biochemical data available C. beijerinckii, we integrated 
and cross-checked information from three major annotation databases to reconstruct the core metabolic 
network, and then further completed the network with computational algorithms and manual curation.  
We collected experimental fermentation data to determine production rates of acetone, ethanol, and 
butanol, and uptake rates of acetate and glucose, and these rates were used to confirm the ability of the 
model to accurately represent physiological behavior.  Interestingly, reactions found in all three 
annotation three databases proved to contribute significantly to the actively used reactions in validation 
simulations.  Even though the observed experimental phenotypes were found to exist in the solution space 
of the model, optimal growth simulations on glucose did not predict the expected product profiles—
suggesting the possibility of an alternative cellular objective or additional mechanisms not captured by the 
iCM925 model.  One reaction found to have a strong impact on the predicted product formation rates was 
the hydrogenase reaction—a reaction that has been found to impact solvent formation experimentally as 
well.  Going forward, this model will play a central role in understanding and metabolic engineering 
butanol production by C. beijerinckii.  Additionally, the construction of iCM925 for a lesser-characterized 
microorganism highlighted important areas of investigation (e.g. genome annotations, objective 
functions) for future model-building efforts.  
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Figures 
 
 
Figure 1 Annotation database comparison.  Reaction overlap for the three annotation databases used to build the 
genome-scale metabolic network.  
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Figure 2 Pathway distribution for reactions in iCM925.  The number of reactions that can carry flux are depicted 
in blue and the number that cannot carry flux are depicted in red for each area of metabolism.  Percentages indicate 
overall percent contribution of that pathway to the model.  Blocked reactions were determined by simulating growth 
on glucose minimal media. 
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Figure 3 Comparison of iCM925 simulations with experimental data.  Model and experimental values for 
product fluxes, uptake fluxes and growth rates represent conditions for the 35°C fermentation.  Error bars indicate 
the observed experimental range and diamonds represent the various simulation results. (A) shows the simulation 
results for the case where only acetate and glucose uptake rates are constrained. (B) shows the case where these 
uptake rates, as well as butanol, acetone, and butyrate formation rates are constrained. In (B), the blue diamonds 
represent the case where non-growth associated ATP maintenance is zero and the yellow diamonds represent the 
case where the non-growth associated ATP maintenance is 8.5 mmol/gDW/hr.  
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Figure 4 Origin of active reactions.  Percentages represent the fraction of all active reactions (in the constrained 
simulation, based on 35°C experiments) originating from individual databases, a combination of databases, or other 
sources. 
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Figure 5 Network map of important active reactions.  Network fluxes were determined in 35°C fermentation 
simulations with ATPM=8.5 mmol/gDW/hr. Blue boxes indicate substrates, red colored boxes indicate products, 
and yellow boxes indicate intracellular metabolites only. Numbers next to each reaction name represent flux 
predicted by the model.  Fluxes are not necessarily consistent from one reaction to the next because other, smaller 
flux pathways have interplay with the reactions here. 
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Figure 6 Flux Variability Analysis of important active reactions.  Bars depict the possible range (minimum and 
maximum) fluxes calculated by Flux Variability Analysis for reactions depicted in Figure 5. 
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Figure 7 Effect of hydrogen formation rate with fixed glucose and acetate uptake.  H2 output flux was varied to 
examine the effect of hydrogen production on predicted formation rates for butyrate, acetone, butanol, ethanol, and 
biomass.  Glucose and acetate uptake rates were fixed to 9.39 and 3.41 mmol/gDW/hr, respectively, and non-growth 
associated maintenance was set to 8.5 mmol/gDW/hr.  Note that while positive ethanol formation is not depicted in 
the plot, FVA found ethanol and butanol production to be interchangeable, with no detrimental result to growth 
rate—likely because the net consumption of NADH is identical in both scenarios.  Experimentally, ethanol 
formation happens at a slower rate than butanol formation.  
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Figure 8 Effect of hydrogen formation rate with fixed glucose uptake only.  H2 output flux was varied to 
examine the effect of hydrogen on the production of acetate, butyrate, acetone, butanol, ethanol and biomass for 
optimal growth simulations on only glucose, with an uptake rate of 9.39 mmol/gDW/hr and a non-growth associated 
ATP maintenance of 8.5 mmol/gDW/hr. Note that while positive ethanol formation is not depicted in the plot, FVA 
found ethanol and butanol production to be interchangeable with no detrimental result to growth rate. 
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Figure 9 Comparison of iCM925 with the Senger & Papoutsakis C. acetobutylicum model.  The number, 
database distribution, and pathway distribution of reactions in iCM925 and the Senger & Papoutsakis C. 
acetobutylicum model were compared based on KEGG IDs. (A) Numbers of reactions in common between the two 
models or unique to each are depicted by bars on the graph.  The fractions of unique and shared reactions that are 
active in iCM925 are denoted by light-shaded regions. (B) The database distribution of reactions exclusive to 
iCM925 are shown in the upper left, while the pathway distribution is shown in the bottom of the panel. 
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Tables 
 
 
Table 1 Network statistics for genome-scale models of clostridia.  Statistics for each published genome-scale 
clostridia model and comparison with iCM925.  
 
 
 
C. beijerinckii 
iCM925 
C. acetobutylicum 
(Lee)[21] 
C. acetobutylicum 
(Senger)[22, 23] 
C. cellulolyticum [25] 
C. thermocellum 
iSR432 [24] 
Genome 6.0 Mb 4.1 Mb 4.1 Mb 4.1 Mb 3.8 Mb 
Protein Coding 
Genes 
5100 3748 3748 3488 3236 
Model Genes 925 432 474 431 432 
Reactions 941 507 552 621 577 
Metabolites 821 479 422 603 525 
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Appendix A: Model Details 
 
Supplemental file iCM925.xls contains detailed information about the following aspects of the iCM925 
model, as presented in this thesis:  
 
 reaction information (reactionData) 
 metabolite information (metaboliteData) 
 reaction additions from BiGG based on GapFill suggestions and BLAST scores (GapFill 
additions from BiGG) 
 biomass equation and details about its construction (Biomass Composition) 
 fatty acid and phospholipid molecular formulas (Phospholipid Formulas) 
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Appendix B: Annotation Database Gene-Protein-Reaction (GPR) Agreement  
 
Figure B.1 shows the agreement for the gene-protein-reaction associations (GPRs) of each included 
reaction. One GPR is defined for each reaction, and a shared GPR is defined as an exact overlap (i.e., 
every associated gene is identical).  Figure B.2 shows the overlap for genes annoated in each database, 
irrespective of their associated reaction.  
 
Figure B.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.2 
 
 
  
34 
 
Appendix C: Annotation Database Pathway Contribution 
 
In addition to overall pathway counts, pathway counts for the the reaction ―sets‖ from each annotation 
database were determined to investigate the contribution of each database in various areas of the network. 
The pathway distribution for each database was found to be similar, illustrating that each database 
performed similarly in all areas of metabolism. 
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Appendix D: Experimental Data 
 
To obtain substrate uptake and product formation rates we performed 100 batch fermentations for four 
different temperature conditions: 30°C, 33°C, 35°C, and 40°C. Over the course of the fermentation we 
measured concentration of glucose, acetate, butyrate, acetone, butanol, ethanol and biomass. Biomass 
concentration was determined using the correlation of 1 OD = 0.28 mg/mL. All fermentations were run in 
a Sixfors bioreactor under continuous nitrogen flow and stirring at 50 rpm. Product concentrations were 
determined using gas chromatography, and glucose concentration was determined using high pressure 
liquid chromatography. Presented experimental data includes: growth curve and product concentration, 
glucose concetnration and pH profiles. 
 
30°C Fermentation Profiles, I 
 
     
 
     
 
30°C Fermentation Profiles, II 
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30°C Fermentation Profiles, III 
 
   
 
 
 
33°C Fermentation Profiles, I 
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33°C Fermentation Profiles, II 
 
   
 
   
 
33°C Fermentation Profiles, III 
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35°C Fermentation Profiles, I 
 
   
 
   
 
35°C Fermentation Profiles, II 
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40°C Fermentation Profiles, I 
 
   
 
   
 
40°C Fermentation Profiles, II 
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40°C Fermentation Profiles, III 
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Appendix E: Substrate Uptake Rates & Product Formation Rates 
 
For each reactor we calculated the growth rate, glucose and acetate uptake rates, and acetone, ethanol, 
butanol and ethanol formation rates. These were calculated by multiplying yield and growth rate (see 
Methods), and averaged for each temperature. Inputs and outputs for the model were constrained to fall 
within one standard deviation of the average. Simulations run include all measured metabolites 
constrained with ATPM=0 and an ATPM value that aligns the simulated and experimental growth rates, 
as well as with only acetate and glucose constrained (ATPM=0). All rates are in units of mmol/gDW/hr. 
 
Growth Glucose Acetone Ethanol Butanol Acetate Butyrate
Reactor 1 0.127 -5.07 2.6 0.11 2.19 -2.56 2.35
Reactor 2 0.105 -3.37 2.08 0.1 1.87 -1.8 0.95
Reactor 3 0.106 -3.12 2.28 0.1 2.02 -2.59 0.96
Average 0.11 -3.85 2.32 0.10 2.03 -2.32 1.42
Standard Deviation 0.01 1.06 0.26 0.01 0.16 0.45 0.81
Simulation Result, ATPM = 0 0.14 -4.91 2.06 0.09 1.87 -1.87 0.85
Simulation Result, ATPM = 2.5 0.11 -4.91 2.06 0.09 1.87 -1.87 1.06
Simulation Result, ac+glc only 
constrained, ATPM=0 0.17 -4.91 1.69 0 0 -1.87 2.97
30 C
 
Growth Glucose Acetone Ethanol Butanol Acetate Butyrate
Reactor 1 0.116 -5.47 2.42 0.09 2.68 -4.58 0.69
Reactor 2 0.148 -5.39 2.96 0.12 3.39 -4.06 0.00
Reactor 3 0.105 -4.34 1.90 0.10 2.55 -4.20 0.69
Average 0.12 -5.07 2.43 0.10 2.87 -4.28 0.46
Standard Deviation 0.02 0.63 0.53 0.02 0.45 0.27 0.40
Simulation Result, ATPM = 0 0.15 -5.7 2.96 0.12 2.77 -4.01 0.86
Simulation Result, ATPM = 2 0.12 -5.7 2.96 0.12 2.96 -4.01 0.86
Simulation Result, ac+glc only 
constrained, ATPM=0 0.18 -5.7 2.94 0 0 -4.01 3.47
33 C
 
Growth Glucose Acetone Ethanol Butanol Acetate Butyrate
Reactor 1 0.16 -8.71 3.99 0.17 4.64 -3.61 0
Reactor 2 0.165 -9.27 4.43 0.18 4.63 -3.44 0.68
Average 0.16 -8.99 4.21 0.18 4.64 -3.53 0.34
Standard Deviation 0.00 0.40 0.31 0.01 0.01 0.12 0.48
Simulation Result, ATPM = 0 0.26 -9.39 3.90 0.17 4.63 -3.41 0.61
Simulation Result, ATPM = 8.5 0.16 -9.39 4.42 0.17 4.63 -3.41 0.82
Simulation Result, ac+glc only 
constrained, ATPM=0 0.32 -9.39 3.14 0.00 0.00 -3.41 5.68
35 C
 
Growth Glucose Acetone Ethanol Butanol Acetate Butyrate
Reactor 1 0.106 -11.42 3.08 0.3 4.46 -3 0
Reactor 2 0.164 -15.56 4.66 0.43 7.8 -4.45 -0.34
Reactor 3 0.143 -10.44 3.47 0.34 5.79 -3.25 -0.21
Average 0.14 -12.47 3.74 0.36 6.02 -3.57 -0.18
Standard Deviation 0.0294 2.71767 0.82306 0.06658 1.6815 0.77513 0.17156
Simulation Result, ATPM = 0 0.42 -15.19 4.56 0.43 7.7 -2.79 -0.01
Simulation Result, ATPM = 20.5 0.14 -15.19 4.56 0.43 7.7 -2.79 -0.01
Simulation Result, ac+glc only 
constrained, ATPM=0 0.53 -15.19 3.14 0 0 -2.79 9.64
40 C
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Appendix F: Flux Variability Analysis 
 
Flux Variability Analysis (FVA) was performed for the simulation where all measured inputs and outputs 
were constrained to the experimentally calculated values. Depicted below are reactions that could increase 
or decrease by 25% of their value predicted by FBA during optimal growth. 
 
Reaction Min Max Actual 
ACCOAC 0 0.240469 0.24047 
ACCOACDL 0 0.240469 0 
ACGK 0.0176392 0.0414477 0.017639 
ACHBS 0 0.195833 0.074017 
ACK -3.51612 1.00408 0 
ACLS 0 0.195833 0.12181 
ACOTA -0.0414477 -0.0176392 -0.017639 
AGPR -0.0414477 -0.0176392 -0.017639 
AHBNOOR 0 0.0740176 0 
AHBPL -1.22E-01 0.0740176 0 
AHDHPT -1.37E-32 0.002957 0 
ALMM 0 0.121815 0 
ALPL -0.121815 0.0740176 0.00E+00 
ASPO4 0 0.0037555 9.65E-32 
ASPO5 0 0.0037555 0.0037555 
BCOPBT 0.719299 5.23944 1.7234 
BTNCC 0 0.240469 0 
BUTK 0.719299 5.23944 1.7234 
BUTOHDx 0 4.63007 4.63 
BUTOHDy 0 4.63007 0 
COAT1 0 4.52 3.516 
COAT2 0 4.52 0.90337 
DHDPRx 0 0.077931 0.077931 
DHDPRy 0 0.077931 0 
DHFR 0 7.61E-03 0.0076081 
DHFRx 0 0.0076082 0 
DHMBDH -0.121815 2.12E-30 0.00E+00 
DMPOR -0.0740176 0 0 
FAPNTPDH 0 0.002957 3.53E-33 
FDH 0 16.7859 2.05E+00 
FDHy 0 12.961 6.9053 
FDXNRx -19.7627 8.03942 3.50E-29 
FDXNRy 0 12.961 0 
FRD2 0 0.0038279 9.65E-32 
FTHFL 0.0861169 0.125716 0.086117 
G3PD1 0 0.241802 0 
G3PD2 0 0.241802 0.15897 
G3PD5 0 0.0828356 0 
G5SD 0 0.0238004 0.0238 
GALT 0 0.0425806 0 
GALU 0 0.0425806 0.04258 
GARFT 0 0.0395701 0 
GARFT2 0.00E+00 0.0395701 0 
GART 0 0.0395701 0.03957 
GDH -1.35E-32 0.002957 0 
GLU5K 0 0.0238004 0.0238 
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GLUSF 0 1.23296 1.2329 
GLUSy 0 1.23296 0 
GLYCLTDx 0 0.0828356 0.00E+00 
GLYCTO2 0.002957 0.0857925 0.002957 
GTP89H 0 0.002957 4.23E-33 
GTPCI 0 0.002957 0.002957 
HACD1x 0 5.45007 0 
HACD1y 0 5.45007 5.45 
HISTD 0 0.0082711 0.008271 
HISTDOR 0 0.0082711 0 
HISTOR 0 0.0082711 0 
HSDx 0 0.263926 0 
HSDy 0 0.263926 0.2639 
Hex 0 0.0002171 0 
KARA1 0 0.121815 0.12181 
KARA2 0 0.0740176 0.074017 
MTHFC -0.0778749 -0.0382761 -0.038276 
MTHFR2 0 0.0319094 0.031909 
MTHFR3 0 0.0319094 0.00E+00 
NADH16 0 0.0414178 0.041398 
NDPK1 -8.62895 0.0656285 -1.63E-30 
NDPK4 0.0046512 0.0245817 0.0046512 
NDPK5 -8.6725 0.0220734 0 
NDPK6 -0.0046994 0.0199305 0 
NDPK7 0 0.0220734 0.0021429 
NDPK8 -8.66999 0.0245817 0 
NDPK9 0 0.0199305 0 
NH42ex 0 0.0004342 0 
ORNTA 0 0.0238004 0 
ORNTAC 0.0175668 0.0414477 0.017639 
P5CR 0 0.0238004 0.0238 
P5CRx 0 0.0238004 0 
PFL 0.109044 16.895 9.0615 
PI2ex 0 0.0002171 0 
POPT 0 8.67464 0.045698 
POR4 0 16.7859 7.8334 
PPNCL2 0 0.0017157 0 
PPNCL3 0 0.0017157 0.0017157 
PPND 0 0.0210997 0.0211 
PPND2 0 0.0210997 0 
PTA -3.51612 1.00408 0 
PYK 0 8.67464 8.6221 
PYK2 0 8.67E+00 0.0046512 
PYK3 0 8.67464 0.0021429 
PYNP2 -0.0199064 7.24E-05 -0.019858 
RNDR3 0 0.0022152 0.0021429 
RNDR4 0 0.0046994 0.0046512 
RNTR3 0 0.0022152 0 
RNTR4 0 0.0046994 0 
SHK3D 0 0.0493824 0.049373 
SHK3Dx 0 0.0493824 0 
TDPAT 0 0.195833 0 
TRPS1 0 0.0033759 0.0033759 
TRPS2 0 0.0033759 0 
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TRPS3 0 0.0033759 0 
UAPGR 0 0.0171629 0.017163 
UAPGRx 0 0.0171629 0 
UGLT -0.0425806 0 0 
UPPRT 0 0.0199305 0 
URIK1 0 0.0199305 1.99E-02 
URIK2 0 0.0199305 0 
URIK3 0 0.0199305 1.33E-35 
URIK4 0 0.0199305 0 
URIK5 0 0.0199305 0 
URIK6 0 0.0199305 0 
URIK7 0 0.0199305 0 
URIK8 0 0.0199305 0 
URIK9 0 0.0199305 0 
 
 
